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The persistence of infected T cells harbouring intact HIV proviruses is the barrier to the eradication of 
HIV. This reservoir is stable over long periods of time despite antiretroviral therapy. There has been 
controversy on whether low level viral replication is occurring at sanctuary sites periodically reseeding 
infected cells into the latent reservoir to account its durability. To study viral evolution in a physiologically 
relevant population of latent viruses, we repeatedly performed virus outgrowth assays on a stably 
treated HIV positive patient over two years and sequenced the reactivated latent viruses. We sought 
evidence of increasing sequence pairwise distances with time as evidence of ongoing viral replication. 
64 reactivatable latent viral sequences were obtained over 103 weeks. We did not observe an increase 
in genetic distance of the sequences with the time elapsed between sampling. No evolution could 
be discerned in these reactivatable latent viruses. Thus, in this patient, the contribution of low-level 
replication to the maintenance of the latent reservoir detectable in the blood compartment is limited.
The principal barrier to the eradication of HIV is a reservoir of latently infected cells that serves as a source of 
viral recrudescence upon cessation of antiretroviral therapy (ART). The most widely studied latent virus pool is 
that found in circulating resting CD4+ T cells. This reservoir is stable despite years of effective ART; the mecha-
nisms by which it is maintained are incompletely understood. Longitudinal studies conducted on patients under 
ART examining reactivatable latent viruses in children1, and proviral DNA together with pre-treatment plasma 
viral RNA in children2 and adults3, have not revealed any evidence of viral evolution in the blood compartment, 
suggesting that persistent viral replication does not contribute to the stability of the reservoir. However, recent 
findings indicate that low level ongoing viral replication occurs at sanctuary sites such as lymphoid tissue despite 
effective ART in some patients4,5. An alternative, but not mutually exclusive, hypothesis is that clonal expansion 
of latently infected cells is involved in the stability of the latent reservoir6–8.
Here we report a case study conducted over 103 weeks on an HIV positive patient diagnosed with haemo-
chromatosis, the treatment for which demanded frequent large volume venesection. This offered an opportunity 
to study the evolution and clonality of replication competent latent viruses in the blood compartment. Strikingly, 
but consistent with previous longitudinal studies, over this two-year period no ongoing evolution was observed 
in this rigorously defined, physiologically relevant latent HIV reservoir.
Methods
Ethics. The participant gave written informed consent and this study was approved by the National Health 
Services (NHS) Health Research Authority (UK) under REC reference 12/SC/0679. All experimental procedures 
were approved by the institutional review board of the University of Cambridge and were performed in accord-
ance with the relevant guidelines.
Outgrowth assay. PBMCs were isolated from whole blood by gradient density centrifugation using 
Lymphoprep (Stemcell Technologies). CD69-CD25-HLA-DR- resting CD4 + T-cells were isolated by negative 
selection using a custom antibody kit (Stemcell Technologies). Cells were seeded at 0.3–0.5million cells per well 
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and stimulated with 2 μg/ml phytohaemagglutinin, a 10 fold excess of irradiated allogenic PBMC and 10 units/
ml IL-2. 0.1 or 0.5million SupT1-CCR5 feeder cells were added to each well and maintained in culture for up to 
21 days9.
Generation of HIVNL4–3 infected cells. 293 T cells were transfected with the plasmid pNL4-3 by the cal-
cium phosphate method. Virus-containing supernatant was harvested 48 hours after transfection. SupT1-CCR5 
cells were infected by spinoculation. After infection, the supernatant was thoroughly washed away. Limiting dilu-
tion of infected cells was performed and mixing with uninfected SupT1-CCR5 cells such that overall number of 
cells seeded into each well was constant at 0.1million cells/well. Cultures showing cytopathy were expanded and 
maintained for a total of 21 days.
Viral RNA extraction and sequencing. Viral RNA was extracted from virus containing superna-
tants of positive wells using QIAamp Viral RNA Mini Kit (Qiagen). Viral RNA was converted to cDNA using 
the High Capacity cDNA reverse transcription kit (Thermo Fisher). cDNA was purified (Qiagen). Gag and 
env amplicons were generated with the following primers: gag forward GGGGACATCAAGCAGCCAT; 
gag reverse CAGCCCTTTTTCCTAGGGGC; env forward TGTGTACCCACAGACCCCAA; env reverse 
CTTCCTGCTGCTCCCAAGAA using GoTaq DNA Polymerase (Promega). PCR was conducted with the fol-
lowing conditions: initial denaturation 95 °C for 2 minutes, amplification 35 cycles of 95 °C for 1 minute, 58 °C 
for 30 seconds, 72 °C for 90 seconds, final elongation 72 °C for 5 minutes. PCR products were purified (Qiagen). 
Sequencing was carried out on an ABI 3730xl DNA Analyzer (GATC and Eurofins).
Sequence analysis. Sequence chromatograms were examined manually and base calls corrected. Sequences 
were aligned using ClustalΩ and alignments were manually inspected. Pairwise distance was computed using the 
pairwise deletion method. All ambiguous positions were removed for each sequence pair. Dendrograms were 
constructed based on pairwise distance data using Mega7. Linear regression was performed using Prism 5.
Results
The HIV positive patient involved in this study had been stably treated with ART for over 7 years. The patient had 
experienced a ‘blip’ 6 months prior to the study, but aside from this had maintained an undetectable viral load 
(<50 copies/ml) from six months prior to the start of this study and through the entire sampling period (Table 1).
Blood draws of 200–600 ml were obtained at 9 time points over 103 weeks. In order to determine the genetic 
makeup of replication competent HIV from the latent reservoir, resting CD4+ T cells (CD69−CD25−HLA-DR−) 
were isolated and seeded into a limiting dilution viral outgrowth assay9. Latent HIV was reactivated by stimula-
tion of T cells with PHA and irradiated allogeneic PBMCs. The activated cells were co-cultured with SupT1-CCR5 
feeder cells for 21 days to amplify any released virus. Wells were determined to be positive for virus outgrowth 
when cytopathic effect was observed by microscopy. In our experience, directly observed cytopathic effect 
approximates a near perfect correlation with release of viral capsid protein p24 as determined by ELISA, as 
reported previously9. In approximately half of all wells seeded with 0.5 million resting CD4+ T cells, virus out-
growth was observed. Thus the majority of wells at this or higher dilutions could be expected to contain a single 
reactivatable replication competent latent virus. Viral RNA was extracted from the supernatant of positive wells 
at this or higher dilutions and reverse transcribed. Amplicons were generated in gag and sequenced by Sanger 
sequencing. 64 viral sequences were obtained over the study period; these were aligned and trimmed to yield a 
534 bp region of gag corresponding to nucleotide 1475 to 2011 of HIV strain HXB2.
To control for nucleotide mutations introduced by the virus outgrowth procedure and errors introduced by 
reverse transcription, amplicon generation and sequencing steps, SupT1-CCR-5 cells were infected with a labora-
tory virus, HIVNL4-3, and a limiting dilution procedure was performed. At the dilution where cytopathic effect was 
observed in no more than half of the wells, the majority of the wells could be expected to have received no more 
than one infectious unit. These infected cells were cultured for a total of 21 days to mimic the virus outgrowth 
assay. Viral RNA was extracted from the supernatants of these wells and sequenced using the same method as 
for the patient samples. We obtained 24 control sequences. At the corresponding 534 bp region of gag as the 
patient samples all control sequences derived from the HIVNL4-3 cultures were identical. Thus differences in viral 
sequence detected in the patient samples are likely to reflect underlying diversity of the reactivated provirus rather 
than spontaneous mutations or errors introduced by the experimental technique.
60 year old male
Time since HIV diagnosis: 7 years
Time on treatment: 7 years
Nadir CD4+ count: 30 cells/μl
Peak viral load: 5.6 log copies/ml
Treatment regimen: Tenofovir, emtricitabine, boosted atazanavir
CD4+ count at start of sampling: 440 cells/μl
Viral Load at time of sampling < 50 copies/ml
Time since last viraemia: 47months
Time since last blip (viral load > 50 copies/ml on single sample): 6 months
Table 1. Profile of the patient involved in the study.
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To detect evidence of new viruses seeding into the latent reservoir we constructed a dendrogram using the 
neighbour joining method, seeking any increasing sequence divergence with time. No obvious pattern with 
respect to time of sampling emerged (Fig. 1). To ensure that our observation had not arisen due to the method of 
analysis, we also analysed the sequencing data using the maximum likelihood method and maximum parsimony 
Figure 1. Dendrogram constructed using the neighbour joining method from 64 gag sequences obtained from 
replication competent virus activated from resting CD4+ T cells from the patient donor. Branch lengths as 
indicated by the scale bar represent the p-distance between sequence pairs. Grey boxes represent isolates which 
could not be distinguished using their gag sequence alone. The pink box highlights eight viruses with identical 
gag sequences which could not be discriminated by sequencing env. The dots are coloured according to the key 
to show date of sampling. There is no apparent clustering by time of sampling.
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method and again found no evidence of clustering by time of sampling (Supplementary Figure 1). To analyse this 
further we used a linear regression of time between sampling and pairwise distance for each pair of sequences 
(Fig. 2) which provided no evidence that sequences increased in diversity the further apart in time they were 
sampled (p = 0.57).
From the dendrogram four clusters of identical sequences were observed. These consisted of a large group 
of 13 sequences, two groups of three sequences and one group of two. Sequencing of env was attempted on the 
viruses in which gag sequences were identical. This allowed 5 of the 13 viruses in the large cluster and all viruses 
in the smaller clusters to be discriminated, as pairwise differences of env between these apparently identical 
viruses are higher than that of the corresponding env regions in the control sequences. The remaining 8 out of 64 
sequences could not be distinguished.
Discussion
Here we report on the sequence diversity of replication competent latent HIV derived from T cells isolated over 
103 weeks. We utilized resting CD4+ T cells so that only latently infected cells are included, and our method 
ensured that the only sequences included were derived from reactivatable, replication competent viruses. Whilst 
several recent studies have provided information on the sequences of replication competent, latent HIV6,10 longi-
tudinal data remain scarce1.
Although the patient required regular therapeutic venesections for haemochromatosis, the condition is not 
known to affect HIV latency. Unlike post mortem studies, the data are free from confounders caused by terminal 
ill health, such as the inability of the patient to take or absorb antiretrovirals. Furthermore, our data are unaffected 
by potential artefacts due to co-morbidities such as malignancy.
We hypothesise that if low-level replication was responsible for the maintenance of the reservoir of latently 
infected resting CD4+ T cells, viral evolution would occur over time and viruses sampled at time points closer 
together should be more similar than those sampled further apart. Instead the results show no relationship 
between the similarity of the viral sequences and sampling time. Thus we have found no evidence of ongoing 
evolution in the latent reservoir in this stably treated patient. This observation is consistent with other longitu-
dinal studies conducted on material from the blood compartment1–3 and is in contrast with studies which have 
identified ongoing evolution in tissue reservoirs4,5. Therefore, if ongoing replication is occurring, its contribution 
to the maintenance of the reservoir of latently infected resting CD4+ T cells in the blood compartment is limited.
It has been suggested that clonal proliferation of latently infected cells contributes to the maintenance of 
the latent HIV reservoir. Clonally expanded sequences have been reported in the residual viraemia or rebound 
viraemia of treated patients7,11–14. Isolation of HIV with identical sequences from the latent reservoir of infected 
patients was reported recently6,15. Possible clonal viruses can also be discerned from our data with 8 out of 64 
sequences that  could not be distinguished. We did not detect a large clone of latently infected cells reminiscent 
of the ‘predominant plasma clone’ described in residual viraemia13. Thus, if homeostatic proliferation were a 
mechanism involved in the maintenance of the latent reservoir in this patient, each clone has proliferated only to 
a limited extent and constitutes only a fraction of the reservoir.
We have focused the main analysis on a region in gag. This was a pragmatic choice. Compared with some other 
regions of the viral genome, gag is less likely to evolve ex vivo during the virus amplification process. Data on con-
served sequences in gag are available to facilitate primer design16, and in our experience amplicons for sequencing 
could be generated reliably from this region. An in silico analysis by Laskey et al. has revealed that no individual 
viral sub-genomic region is superior to another in predicting clonality, and the ability to predict clonality with 
sub-genomic sequencing varies with sample type17. Their analysis did not include viral sequences obtained from 
outgrowth assays. As we have not obtained the sequences of whole viral genomes we cannot definitively deter-
mine clonality. However, the proportion of potentially identical isolates from different wells of virus outgrowth 
(8/64) in our study is consistent with other studies10.
Figure 2. Linear regression of p-distance and time between sampling. For each pair of samples we compared 
the pairwise distance and the time elapsed between the samples being taken. No association between time of 
sampling and p-distance was identified (r2 = 0.00016, p = 0.573).
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There are some limitations in this study. We have not sequenced the integrated proviruses and thus cannot 
absolutely exclude the possibility of artefacts introduced by virus outgrowth, although this would likely have 
increased diversity rather than led to sequence conservation. We limited our study to the blood compartment to 
avoid the risks of invasive sampling to the patient. We note that others have reported that HIV reservoir in the 
blood compartment may not recapitulate that of the tissue compartments4 but at least some latently infected cells 
in the blood are found to derive from lymphoid tissues. Finally, an important limitation is that our data is derived 
from a single patient. Nonetheless, carefully conducted studies based on individual patients have previously pro-
vided important insights into HIV latency18,19.
In contrast to the evidence of evolution of HIV in tissues over six months despite effective ART4, longitudinal 
follow up over 103 weeks has not revealed evidence of ongoing evolution of the replication competent latent 
HIV-1 reservoir in the blood compartment in this stably treated patient.
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